Current opinion on adjuvant and salvage treatment after radical prostatectomy

Clinical Oncology

Volumn 16, Issue 4, 2004, Pages 277-282

  Morris, S L ^a   Parker, Christopher C ^a   Huddart, R ^a   Horwich, A ^a   Dearnaley, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Adjuvant treatment; Current opinion; Prostate cancer

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FOLLOW UP; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; TREATMENT INDICATION;

EID: 2542574742     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.03.004     Document Type: Article

References (13)

1. The BAUS Cancer Registry (BCR) BAUS section of Oncology (2001) 'Analyses of minimum data set for Urological Cancers', 1 January-31 December, 2000.
2. Messing E, Manola J, Sarosdy M, et al. Immediate Hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999;341:1781-1788.
3. See W, Iversen P, Wirth M, et al. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer. Eur Urol 2003; 44:512-517 discussion 517-518.
4. Parker C, Warde P, Catton C. Salvage radiotherapy for PSA failure after radical prostatectomy. Radiother Oncol 2001; 61:107-116.
5. Ornstein DK, Colberg JW, Virgo KS, et al. Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology 1998;52:1047-1054.
6. Duchesne GM, Millar JL, Moraga V, et al. What to do for prostate cancer patients with a rising PSA? A survey of Australian practice. Int J Radiat Oncol Biol Phys 2003;55:986-991.
7. National Institute for Clinical Excellence. Guidance on cancer services. Improving outcomes in urological cancer, September 2002 www.nice.org.uk
8. COIN GUIDELINES. Guidelines on the Management of Prostate Cancer. Clin Oncol 1999;11:S55-S66.
9. Connolly JA, Shinohara K, Presti JC Jr, et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996;47:225-231.
10. RTOG p0011 Trial Protocol. www.rtog.org/members/protocols/p0011/p0011.pdf.
11. Schild SE, Wong WW, Grado GL. The results of radical retropubic prostatectomy and adjuvant therapy for pathological stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996;34:535-541.
12. Syndikus I, Pickles T, Kostashuk E, et al. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 1996;155:1983-1986.
13. Valicenti RK, Gomella LG, Ismail M, et al. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1999;45:53-58.